HIV Monotherapy
The Basics
News & Research
- Boosted Darunavir Monotherapy Works Well in Two Studies (July 23, 2009)
Ritonavir-boosted darunavir alone maintains HIV suppression in most patients who achieved an undetectable viral load on combination antiretroviral therapy, according to two studies.
From aidsmap.com
- Does Kaletra Monotherapy Work? Depends on Who You Ask (October 27, 2008)
Project Inform says the latest findings on Kaletra monotherapy are anything but positive.
From Project Inform
- Predictors of Virologic Rebound on Lopinavir/Ritonavir Monotherapy (February 28, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Resistance Analysis of Lopinavir/Ritonavir Maintenance Therapy Study (February 27, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Cal Cohen, M.D., Comments on Atazanavir Monotherapy (February 8, 2006)
Dr. Cohen's thoughts appear toward the end of this exclusive interview from CROI 2006.
In The 13th Conference on Retroviruses and Opportunistic Infections
- Los Angeles Times Examines Drug Resistance in HIV-Positive People Who Have Undergone Monotherapy (January 20, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Lamivudine Monotherapy Better Than Treatment Interruption in Rescue Patients With M184V (July 27, 2005)
[Archived Article]
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
- No Rapid Selection of Resistance Is Observed When Lopinavir/Ritonavir "Monotherapy" Fails (October 30, 2004)
In The 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Recap of Recent Research on Kaletra Monotherapy (September/October 2004)
In Positively Aware, from Test Positive Aware Network
- What Lopinavir/Ritonavir Monotherapy Does for Your Lipids (July 16, 2004)
In The XV International AIDS Conference
- Kaletra "Monotherapy" Safe and Efficacious for Treatment-Naive Patients (September 15, 2003)
[Archived Article]
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- "Mono"-Therapy for HIV Infection Using Ritonavir-Boosted Indinavir (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Drug Economy (July/August 2001)
[Archived Article]
Antiretroviral renegade fights fashion with didanosine + Hydroxyurea duo, betting his future on genetic barriers.
In TAGline, from Treatment Action Group
|
|
Advertisement
|
E-Mail
Glossary
Share
